Matthew J. Koster

The Mayo Clinic Histiocytosis Working Group Consensus Statement for the Diagnosis and Evaluation of Adult Patients With Histiocytic Neoplasms: Erdheim-Chester Disease, Langerhans Cell Histiocytosis, and Rosai-Dorfman Disease

Gaurav Goyal, Jason R. Young, Matthew J. Koster et al. · Mayo Clinic Proceedings · 2019 · 191 citations

Veterinary Medicine, Pathology, Cellular Pathology +12

Translation of cytoplasmic UBA1 contributes to VEXAS syndrome pathogenesis

Marcela A. Ferrada, Sinisa Savic, Daniela Ospina Cardona et al. · Blood · 2022 · 186 citations · Full text

Life Sciences, Genetics, Molecular Biology +7

Predictors of relapse and treatment outcomes in biopsy-proven giant cell arteritis: a retrospective cohort study

C. Labarca, Matthew J. Koster, Cynthia S. Crowson et al. · Lara D. Veeken · 2015 · 169 citations · Full text

Medicine, Pharmacotherapy, Clinical Epidemiology +12

Clinical Heterogeneity of the VEXAS Syndrome

Matthew J. Koster, Taxiarchis Kourelis, Kaaren K. Reichard et al. · Mayo Clinic Proceedings · 2021 · 107 citations

Life Sciences, Genetics, Neurology +8

Spectrum of clonal hematopoiesis in VEXAS syndrome

Fernanda Gutierrez‐Rodrigues, Yael Kusne, Jenna Fernandez et al. · Blood · 2023 · 103 citations · Full text

Medicine, Cell Biology, Hematology +14